Creative Planning boosted its holdings in shares of DuPont de Nemours, Inc. (NYSE:DD – Get Rating) by 18.2% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 81,411 shares of the basic materials company’s stock after acquiring an additional 12,519 shares during the quarter. Creative Planning’s holdings in DuPont de Nemours were worth $4,103,000 at the end of the most recent quarter.
A number of other institutional investors also recently modified their holdings of DD. Moisand Fitzgerald Tamayo LLC bought a new position in DuPont de Nemours during the second quarter valued at about $27,000. Evoke Wealth LLC raised its stake in DuPont de Nemours by 84.7% in the second quarter. Evoke Wealth LLC now owns 556 shares of the basic materials company’s stock valued at $31,000 after purchasing an additional 255 shares in the last quarter. Montag A & Associates Inc. raised its stake in DuPont de Nemours by 76.0% in the second quarter. Montag A & Associates Inc. now owns 595 shares of the basic materials company’s stock valued at $33,000 after purchasing an additional 257 shares in the last quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC raised its stake in DuPont de Nemours by 833.8% in the third quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC now owns 663 shares of the basic materials company’s stock valued at $33,000 after purchasing an additional 592 shares in the last quarter. Finally, Fairfield Bush & CO. purchased a new stake in DuPont de Nemours in the first quarter valued at approximately $50,000. 71.91% of the stock is owned by institutional investors.
DuPont de Nemours Stock Performance
NYSE:DD opened at $74.94 on Wednesday. The stock’s fifty day moving average is $70.71 and its 200 day moving average is $62.05. DuPont de Nemours, Inc. has a fifty-two week low of $49.52 and a fifty-two week high of $84.08. The firm has a market capitalization of $37.23 billion, a PE ratio of 20.70, a PEG ratio of 3.59 and a beta of 1.43. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.99 and a current ratio of 2.39.
Wall Street Analyst Weigh In
Several research analysts have commented on DD shares. Credit Suisse Group lifted their price target on shares of DuPont de Nemours from $64.00 to $75.00 and gave the stock an “outperform” rating in a research note on Wednesday, November 9th. BMO Capital Markets raised their target price on shares of DuPont de Nemours from $80.00 to $88.00 and gave the stock an “outperform” rating in a report on Wednesday, November 9th. Citigroup raised their target price on shares of DuPont de Nemours from $75.00 to $82.00 and gave the stock a “buy” rating in a report on Thursday, December 15th. StockNews.com began coverage on shares of DuPont de Nemours in a report on Wednesday, October 12th. They issued a “hold” rating on the stock. Finally, Mizuho raised their target price on shares of DuPont de Nemours from $82.00 to $83.00 and gave the stock a “buy” rating in a report on Thursday, January 12th. Five investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $76.79.
About DuPont de Nemours
DuPont de Nemours, Inc operates as a holding company engaged in the development of specialty materials, chemicals, and agricultural products. It operates through the following segments: Electronics & Industrial, Water & Protection, and Mobility & Materials. The Electronics & Industrial segment supplies differentiated materials and systems for a broad range of consumer electronics including mobile devices, television monitors, personal computers and electronics used in a variety of industries.
- Get a free copy of the StockNews.com research report on DuPont de Nemours (DD)
- Pliant Therapeutics Gaps 34% Higher: More Upside To Come?
- How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
- Is the Pain Over for Baudax Bio Investors after a 70% Spike?
- Will Rocket Lab’s First U.S. Launch Send Stock Into Stratosphere?
- 3 Retail Stocks Ringing the Register in 2023
Receive News & Ratings for DuPont de Nemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DuPont de Nemours and related companies with MarketBeat.com's FREE daily email newsletter.